Fragmentation et défragmentation du droit des innovations biomédicales (I-BioLex)
Published January 18, 2023 | Version v1
Poster Open

What are the quality challenges regarding comparability considerations of advanced therapy medicinal products?

Creators

  • 1. Aix-Marseille Université
  • 2. Hôpitaux de Marseille (AP-HM)
  • 3. University of Oxford
  • 4. Aix-Marseille Université, CNRS

Description

Poster presented at the 2022 Conference of the European Association of Health Law (EAHL) in Ghent.

Notes

Also available: https://shs.hal.science/halshs-03780293v1

Files

EAHL 2022- Comparibility considerations of ATMPs.pdf

Files (15.6 MB)

Additional details

Funding

Agence Nationale de la Recherche
I-BioLex - Fragmentation and defragmentation of the law on biomedical innovations ANR-20-CE26-0007